nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Vapreotide—TACR1—asthma	0.00888	0.901	CrCbGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL11—asthma	0.00159	0.00501	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—UTS2—asthma	0.00159	0.00501	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—asthma	0.00158	0.00496	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—BDKRB2—asthma	0.00156	0.00493	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—asthma	0.00156	0.00491	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—asthma	0.00156	0.00491	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—TACR2—asthma	0.00153	0.00482	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR8—asthma	0.00153	0.00482	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR4—asthma	0.00152	0.0048	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL17—asthma	0.0015	0.00473	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—KNG1—asthma	0.00142	0.00448	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—C5—asthma	0.00142	0.00446	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—TACR1—asthma	0.00142	0.00446	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—AGTR1—asthma	0.00141	0.00445	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—asthma	0.0014	0.00441	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR3—asthma	0.0013	0.00408	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—asthma	0.00127	0.00401	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—ITPR1—asthma	0.00127	0.004	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—asthma	0.00127	0.00398	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPY—asthma	0.00126	0.00398	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CYSLTR1—asthma	0.00125	0.00395	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGTR2—asthma	0.00122	0.00384	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—UTS2—asthma	0.00121	0.00381	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—C5AR1—asthma	0.00121	0.00381	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL11—asthma	0.00121	0.00381	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—EDN1—asthma	0.0012	0.00378	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDNRB—asthma	0.00117	0.00367	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR4—asthma	0.00116	0.00365	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPS—asthma	0.00115	0.00364	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—TAC1—asthma	0.00115	0.00364	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—C3AR1—asthma	0.00114	0.0036	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—asthma	0.00114	0.00357	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR3—asthma	0.00113	0.00357	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CYSLTR2—asthma	0.0011	0.00346	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—C5—asthma	0.00108	0.0034	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—TACR1—asthma	0.00108	0.0034	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—asthma	0.00107	0.00338	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PTGDR—asthma	0.00106	0.00334	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—LTB4R—asthma	0.00106	0.00334	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—C3AR1—asthma	0.00104	0.00327	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—BDKRB2—asthma	0.00104	0.00326	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CYSLTR2—asthma	0.000998	0.00314	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR3—asthma	0.000987	0.00311	CbGpPWpGaD
Nafarelin—Desmopressin—PTGS2—asthma	0.000977	0.0991	CrCbGaD
Nafarelin—GNRHR—Signaling by GPCR—LTB4R—asthma	0.000964	0.00304	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PTGDR—asthma	0.000964	0.00304	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL22—asthma	0.000964	0.00304	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—NPY—asthma	0.000962	0.00303	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—KNG1—asthma	0.000942	0.00297	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGTR1—asthma	0.000937	0.00295	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—AGTR2—asthma	0.000928	0.00292	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL10—asthma	0.000915	0.00288	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PMCH—asthma	0.000903	0.00284	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PTGDR2—asthma	0.000903	0.00284	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HRH4—asthma	0.000903	0.00284	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPSR1—asthma	0.000903	0.00284	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	0.000889	0.0028	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—EDNRB—asthma	0.000888	0.0028	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CSF2RB—asthma	0.000883	0.00278	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—TAC1—asthma	0.000879	0.00277	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—NPS—asthma	0.000879	0.00277	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—TACR2—asthma	0.000865	0.00272	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR8—asthma	0.000865	0.00272	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCR3—asthma	0.000862	0.00272	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HRH4—asthma	0.00082	0.00258	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PTGDR2—asthma	0.00082	0.00258	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PMCH—asthma	0.00082	0.00258	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPSR1—asthma	0.00082	0.00258	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CSF2RB—asthma	0.000802	0.00253	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.000794	0.0025	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—BDKRB2—asthma	0.000789	0.00248	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.000788	0.00248	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—TACR2—asthma	0.000786	0.00247	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR8—asthma	0.000786	0.00247	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL17—asthma	0.000771	0.00243	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PDE4A—asthma	0.000756	0.00238	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—asthma	0.000731	0.0023	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—KNG1—asthma	0.000718	0.00226	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—AGTR1—asthma	0.000713	0.00225	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	0.00071	0.00224	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CYSLTR1—asthma	0.000708	0.00223	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCL10—asthma	0.000697	0.0022	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.000694	0.00218	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PDE4A—asthma	0.000687	0.00216	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—C5AR1—asthma	0.000684	0.00215	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—VIP—asthma	0.000684	0.00215	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—UTS2—asthma	0.000684	0.00215	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—ADRB2—asthma	0.000677	0.00213	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR4—asthma	0.000656	0.00207	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CYSLTR1—asthma	0.000643	0.00203	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IL2RB—asthma	0.000631	0.00199	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PDE4D—asthma	0.000626	0.00197	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL11—asthma	0.000621	0.00196	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—UTS2—asthma	0.000621	0.00196	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—C5AR1—asthma	0.000621	0.00196	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—VIP—asthma	0.000621	0.00196	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—FCER2—asthma	0.000613	0.00193	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—C3AR1—asthma	0.000613	0.00193	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—C5—asthma	0.00061	0.00192	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PDE4B—asthma	0.00061	0.00192	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—TACR1—asthma	0.00061	0.00192	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—EDN1—asthma	0.000605	0.0019	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL5—asthma	0.0006	0.00189	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR4—asthma	0.000596	0.00188	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CYSLTR2—asthma	0.00059	0.00186	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL2RB—asthma	0.000573	0.00181	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PTGDR—asthma	0.000569	0.00179	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL22—asthma	0.000569	0.00179	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LTB4R—asthma	0.000569	0.00179	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PDE4D—asthma	0.000568	0.00179	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR3—asthma	0.000558	0.00176	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	0.000555	0.00175	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PDE4B—asthma	0.000554	0.00174	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—C5—asthma	0.000554	0.00174	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—TACR1—asthma	0.000554	0.00174	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPY—asthma	0.000543	0.00171	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	0.000543	0.00171	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR5—asthma	0.000541	0.0017	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—C3—asthma	0.000528	0.00166	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AGTR2—asthma	0.000524	0.00165	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR3—asthma	0.000506	0.00159	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—EDNRB—asthma	0.000502	0.00158	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—TAC1—asthma	0.000497	0.00157	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPS—asthma	0.000497	0.00157	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPY—asthma	0.000493	0.00155	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCR3—asthma	0.000487	0.00153	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPSR1—asthma	0.000484	0.00152	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HRH4—asthma	0.000484	0.00152	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PMCH—asthma	0.000484	0.00152	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PTGDR2—asthma	0.000484	0.00152	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AGTR2—asthma	0.000476	0.0015	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CSF2RB—asthma	0.000474	0.00149	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TACR2—asthma	0.000464	0.00146	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR8—asthma	0.000464	0.00146	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IL5—asthma	0.000462	0.00145	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—EDNRB—asthma	0.000456	0.00144	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL17—asthma	0.000455	0.00143	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPS—asthma	0.000451	0.00142	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—TAC1—asthma	0.000451	0.00142	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—BDKRB2—asthma	0.000446	0.0014	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CXCR3—asthma	0.000443	0.00139	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADCY2—asthma	0.000431	0.00136	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IL3—asthma	0.00043	0.00135	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	0.000429	0.00135	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	0.000424	0.00133	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—POMC—asthma	0.000423	0.00133	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL5—asthma	0.00042	0.00132	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL2—asthma	0.000413	0.0013	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PDE4A—asthma	0.000406	0.00128	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—KIF3A—asthma	0.000406	0.00128	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—KNG1—asthma	0.000406	0.00128	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—BDKRB2—asthma	0.000405	0.00127	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AGTR1—asthma	0.000403	0.00127	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL10—asthma	0.000394	0.00124	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADCY2—asthma	0.000392	0.00123	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL3—asthma	0.00039	0.00123	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADRB2—asthma	0.000382	0.0012	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CYSLTR1—asthma	0.00038	0.0012	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—KNG1—asthma	0.000368	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL11—asthma	0.000367	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—C5AR1—asthma	0.000367	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—UTS2—asthma	0.000367	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CMA1—asthma	0.000367	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—VIP—asthma	0.000367	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AGTR1—asthma	0.000366	0.00115	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ITPR1—asthma	0.000362	0.00114	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CXCL10—asthma	0.000358	0.00113	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR4—asthma	0.000352	0.00111	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADRB2—asthma	0.000347	0.00109	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—STAT6—asthma	0.000345	0.00109	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—EDN1—asthma	0.000342	0.00108	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCL5—asthma	0.000339	0.00107	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL2RB—asthma	0.000339	0.00107	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PDE4D—asthma	0.000336	0.00106	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CSF2—asthma	0.000334	0.00105	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ITPR1—asthma	0.000329	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—C5—asthma	0.000327	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PDE4B—asthma	0.000327	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TACR1—asthma	0.000327	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CXCL8—asthma	0.000327	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	0.000326	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—EDN1—asthma	0.00031	0.000977	CbGpPWpGaD
Nafarelin—Diarrhoea—Flunisolide—asthma	0.00031	0.000461	CcSEcCtD
Nafarelin—Rash—Loratadine—asthma	0.000309	0.000459	CcSEcCtD
Nafarelin—Constipation—Budesonide—asthma	0.000309	0.000459	CcSEcCtD
Nafarelin—Dermatitis—Loratadine—asthma	0.000309	0.000459	CcSEcCtD
Nafarelin—Rash—Tiotropium—asthma	0.000308	0.000459	CcSEcCtD
Nafarelin—Dermatitis—Tiotropium—asthma	0.000308	0.000458	CcSEcCtD
Nafarelin—Nausea—Aminophylline—asthma	0.000308	0.000458	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCL5—asthma	0.000308	0.00097	CbGpPWpGaD
Nafarelin—Urticaria—Montelukast—asthma	0.000307	0.000457	CcSEcCtD
Nafarelin—Headache—Loratadine—asthma	0.000307	0.000457	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—PLA2G4A—asthma	0.000307	0.000966	CbGpPWpGaD
Nafarelin—Headache—Tiotropium—asthma	0.000306	0.000456	CcSEcCtD
Nafarelin—Sweating increased—Betamethasone—asthma	0.000306	0.000454	CcSEcCtD
Nafarelin—Sweating increased—Dexamethasone—asthma	0.000306	0.000454	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCR5—asthma	0.000306	0.000962	CbGpPWpGaD
Nafarelin—Acute coronary syndrome—Triamcinolone—asthma	0.000304	0.000452	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CSF2—asthma	0.000303	0.000955	CbGpPWpGaD
Nafarelin—Acute coronary syndrome—Methylprednisolone—asthma	0.000303	0.000451	CcSEcCtD
Nafarelin—Myocardial infarction—Triamcinolone—asthma	0.000302	0.000449	CcSEcCtD
Nafarelin—Asthenia—Mometasone—asthma	0.000302	0.000449	CcSEcCtD
Nafarelin—Myocardial infarction—Methylprednisolone—asthma	0.000302	0.000448	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—IL2RA—asthma	0.000301	0.000948	CbGpPWpGaD
Nafarelin—Dizziness—Flunisolide—asthma	0.0003	0.000446	CcSEcCtD
Nafarelin—Conjunctivitis—Triamcinolone—asthma	0.0003	0.000446	CcSEcCtD
Nafarelin—Mood swings—Prednisone—asthma	0.000299	0.000445	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCR3—asthma	0.000299	0.000942	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—C3—asthma	0.000299	0.00094	CbGpPWpGaD
Nafarelin—Pruritus—Mometasone—asthma	0.000298	0.000442	CcSEcCtD
Nafarelin—Urticaria—Salbutamol—asthma	0.000296	0.00044	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—NPY—asthma	0.000292	0.000918	CbGpPWpGaD
Nafarelin—Nausea—Loratadine—asthma	0.000291	0.000433	CcSEcCtD
Nafarelin—Epistaxis—Triamcinolone—asthma	0.000291	0.000432	CcSEcCtD
Nafarelin—Nausea—Tiotropium—asthma	0.000291	0.000432	CcSEcCtD
Nafarelin—Dry skin—Prednisone—asthma	0.00029	0.000431	CcSEcCtD
Nafarelin—Vomiting—Flunisolide—asthma	0.000288	0.000429	CcSEcCtD
Nafarelin—Diarrhoea—Mometasone—asthma	0.000288	0.000428	CcSEcCtD
Nafarelin—Urticaria—Budesonide—asthma	0.000287	0.000427	CcSEcCtD
Nafarelin—Rash—Flunisolide—asthma	0.000286	0.000425	CcSEcCtD
Nafarelin—Dermatitis—Flunisolide—asthma	0.000286	0.000425	CcSEcCtD
Nafarelin—Weight increased—Betamethasone—asthma	0.000286	0.000425	CcSEcCtD
Nafarelin—Weight increased—Dexamethasone—asthma	0.000286	0.000425	CcSEcCtD
Nafarelin—Headache—Flunisolide—asthma	0.000284	0.000422	CcSEcCtD
Nafarelin—Weight decreased—Betamethasone—asthma	0.000284	0.000422	CcSEcCtD
Nafarelin—Weight decreased—Dexamethasone—asthma	0.000284	0.000422	CcSEcCtD
Nafarelin—Asthenia—Formoterol—asthma	0.000283	0.000421	CcSEcCtD
Nafarelin—Asthenia—Arformoterol—asthma	0.000283	0.000421	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—PPP2CA—asthma	0.000283	0.00089	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AGTR2—asthma	0.000281	0.000886	CbGpPWpGaD
Nafarelin—Pruritus—Formoterol—asthma	0.000279	0.000415	CcSEcCtD
Nafarelin—Pruritus—Arformoterol—asthma	0.000279	0.000415	CcSEcCtD
Nafarelin—Muscular weakness—Prednisone—asthma	0.000279	0.000415	CcSEcCtD
Nafarelin—Rhinitis—Triamcinolone—asthma	0.000277	0.000413	CcSEcCtD
Nafarelin—Asthenia—Montelukast—asthma	0.000277	0.000413	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCR5—asthma	0.000277	0.000874	CbGpPWpGaD
Nafarelin—Rhinitis—Methylprednisolone—asthma	0.000277	0.000412	CcSEcCtD
Nafarelin—Acute coronary syndrome—Betamethasone—asthma	0.000276	0.00041	CcSEcCtD
Nafarelin—Acute coronary syndrome—Dexamethasone—asthma	0.000276	0.00041	CcSEcCtD
Nafarelin—Abdominal distension—Prednisone—asthma	0.000275	0.000409	CcSEcCtD
Nafarelin—Myocardial infarction—Dexamethasone—asthma	0.000274	0.000408	CcSEcCtD
Nafarelin—Myocardial infarction—Betamethasone—asthma	0.000274	0.000408	CcSEcCtD
Nafarelin—Pruritus—Montelukast—asthma	0.000274	0.000407	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—IL2RA—asthma	0.000273	0.000861	CbGpPWpGaD
Nafarelin—Conjunctivitis—Dexamethasone—asthma	0.000272	0.000404	CcSEcCtD
Nafarelin—Conjunctivitis—Betamethasone—asthma	0.000272	0.000404	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—C3—asthma	0.000271	0.000854	CbGpPWpGaD
Nafarelin—Diarrhoea—Formoterol—asthma	0.00027	0.000402	CcSEcCtD
Nafarelin—Diarrhoea—Arformoterol—asthma	0.00027	0.000402	CcSEcCtD
Nafarelin—Nausea—Flunisolide—asthma	0.000269	0.0004	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—EDNRB—asthma	0.000269	0.000848	CbGpPWpGaD
Nafarelin—Asthenia—Salbutamol—asthma	0.000267	0.000398	CcSEcCtD
Nafarelin—Vomiting—Mometasone—asthma	0.000267	0.000398	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—TAC1—asthma	0.000267	0.00084	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPS—asthma	0.000267	0.00084	CbGpPWpGaD
Nafarelin—Sweating increased—Prednisone—asthma	0.000266	0.000396	CcSEcCtD
Nafarelin—Rash—Mometasone—asthma	0.000265	0.000394	CcSEcCtD
Nafarelin—Dermatitis—Mometasone—asthma	0.000265	0.000394	CcSEcCtD
Nafarelin—Diarrhoea—Montelukast—asthma	0.000265	0.000393	CcSEcCtD
Nafarelin—Pruritus—Salbutamol—asthma	0.000264	0.000392	CcSEcCtD
Nafarelin—Headache—Mometasone—asthma	0.000263	0.000392	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CXCR3—asthma	0.000261	0.000823	CbGpPWpGaD
Nafarelin—Dizziness—Formoterol—asthma	0.000261	0.000388	CcSEcCtD
Nafarelin—Dizziness—Arformoterol—asthma	0.000261	0.000388	CcSEcCtD
Nafarelin—Asthenia—Budesonide—asthma	0.000259	0.000385	CcSEcCtD
Nafarelin—Mental disorder—Hydrocortisone—asthma	0.000258	0.000383	CcSEcCtD
Nafarelin—Malnutrition—Hydrocortisone—asthma	0.000256	0.00038	CcSEcCtD
Nafarelin—Dizziness—Montelukast—asthma	0.000256	0.00038	CcSEcCtD
Nafarelin—Pruritus—Budesonide—asthma	0.000255	0.00038	CcSEcCtD
Nafarelin—Diarrhoea—Salbutamol—asthma	0.000255	0.000379	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CYBA—asthma	0.000253	0.000797	CbGpPWpGaD
Nafarelin—Vomiting—Formoterol—asthma	0.000251	0.000373	CcSEcCtD
Nafarelin—Vomiting—Arformoterol—asthma	0.000251	0.000373	CcSEcCtD
Nafarelin—Nausea—Mometasone—asthma	0.00025	0.000371	CcSEcCtD
Nafarelin—Rash—Arformoterol—asthma	0.000249	0.00037	CcSEcCtD
Nafarelin—Rash—Formoterol—asthma	0.000249	0.00037	CcSEcCtD
Nafarelin—Dermatitis—Arformoterol—asthma	0.000249	0.00037	CcSEcCtD
Nafarelin—Dermatitis—Formoterol—asthma	0.000249	0.00037	CcSEcCtD
Nafarelin—Weight increased—Prednisone—asthma	0.000249	0.00037	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PARP1—asthma	0.000248	0.000781	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL5—asthma	0.000248	0.000781	CbGpPWpGaD
Nafarelin—Headache—Arformoterol—asthma	0.000247	0.000368	CcSEcCtD
Nafarelin—Headache—Formoterol—asthma	0.000247	0.000368	CcSEcCtD
Nafarelin—Weight decreased—Prednisone—asthma	0.000247	0.000368	CcSEcCtD
Nafarelin—Diarrhoea—Budesonide—asthma	0.000247	0.000367	CcSEcCtD
Nafarelin—Dizziness—Salbutamol—asthma	0.000247	0.000367	CcSEcCtD
Nafarelin—Vomiting—Montelukast—asthma	0.000246	0.000366	CcSEcCtD
Nafarelin—Rash—Montelukast—asthma	0.000244	0.000363	CcSEcCtD
Nafarelin—Dermatitis—Montelukast—asthma	0.000244	0.000362	CcSEcCtD
Nafarelin—Depression—Prednisone—asthma	0.000243	0.000361	CcSEcCtD
Nafarelin—Headache—Montelukast—asthma	0.000242	0.00036	CcSEcCtD
Nafarelin—Mental disorder—Methylprednisolone—asthma	0.000242	0.00036	CcSEcCtD
Nafarelin—Malnutrition—Methylprednisolone—asthma	0.00024	0.000357	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisone—asthma	0.00024	0.000357	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—BDKRB2—asthma	0.000239	0.000753	CbGpPWpGaD
Nafarelin—Myocardial infarction—Prednisone—asthma	0.000239	0.000355	CcSEcCtD
Nafarelin—Dizziness—Budesonide—asthma	0.000239	0.000355	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—POMC—asthma	0.000239	0.000752	CbGpPWpGaD
Nafarelin—Vomiting—Salbutamol—asthma	0.000237	0.000352	CcSEcCtD
Nafarelin—Dysgeusia—Triamcinolone—asthma	0.000236	0.000351	CcSEcCtD
Nafarelin—Vertigo—Prednisolone—asthma	0.000235	0.00035	CcSEcCtD
Nafarelin—Rash—Salbutamol—asthma	0.000235	0.000349	CcSEcCtD
Nafarelin—Dermatitis—Salbutamol—asthma	0.000235	0.000349	CcSEcCtD
Nafarelin—Nausea—Formoterol—asthma	0.000235	0.000349	CcSEcCtD
Nafarelin—Nausea—Arformoterol—asthma	0.000235	0.000349	CcSEcCtD
Nafarelin—Headache—Salbutamol—asthma	0.000234	0.000347	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ADCY2—asthma	0.000231	0.000729	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL3—asthma	0.000231	0.000726	CbGpPWpGaD
Nafarelin—Vertigo—Hydrocortisone—asthma	0.00023	0.000342	CcSEcCtD
Nafarelin—Nausea—Montelukast—asthma	0.00023	0.000342	CcSEcCtD
Nafarelin—Vomiting—Budesonide—asthma	0.00023	0.000341	CcSEcCtD
Nafarelin—Rash—Budesonide—asthma	0.000228	0.000339	CcSEcCtD
Nafarelin—Dermatitis—Budesonide—asthma	0.000227	0.000338	CcSEcCtD
Nafarelin—Convulsion—Prednisolone—asthma	0.000227	0.000338	CcSEcCtD
Nafarelin—Headache—Budesonide—asthma	0.000226	0.000336	CcSEcCtD
Nafarelin—Alopecia—Betamethasone—asthma	0.000222	0.00033	CcSEcCtD
Nafarelin—Alopecia—Dexamethasone—asthma	0.000222	0.00033	CcSEcCtD
Nafarelin—Convulsion—Hydrocortisone—asthma	0.000222	0.00033	CcSEcCtD
Nafarelin—Nausea—Salbutamol—asthma	0.000221	0.000329	CcSEcCtD
Nafarelin—Myalgia—Hydrocortisone—asthma	0.000218	0.000324	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—KNG1—asthma	0.000218	0.000685	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—POMC—asthma	0.000217	0.000683	CbGpPWpGaD
Nafarelin—Vertigo—Triamcinolone—asthma	0.000216	0.000322	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—AGTR1—asthma	0.000216	0.000681	CbGpPWpGaD
Nafarelin—Vertigo—Methylprednisolone—asthma	0.000216	0.000321	CcSEcCtD
Nafarelin—Nausea—Budesonide—asthma	0.000214	0.000319	CcSEcCtD
Nafarelin—Oedema—Prednisolone—asthma	0.000214	0.000318	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCL2—asthma	0.000212	0.000668	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6R—asthma	0.000212	0.000666	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CXCL10—asthma	0.000211	0.000666	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—RHOA—asthma	0.00021	0.000663	CbGpPWpGaD
Nafarelin—Shock—Prednisolone—asthma	0.00021	0.000313	CcSEcCtD
Nafarelin—Oedema—Hydrocortisone—asthma	0.000209	0.00031	CcSEcCtD
Nafarelin—Convulsion—Triamcinolone—asthma	0.000209	0.00031	CcSEcCtD
Nafarelin—Convulsion—Methylprednisolone—asthma	0.000208	0.00031	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—NTRK1—asthma	0.000207	0.000653	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Prednisolone—asthma	0.000207	0.000307	CcSEcCtD
Nafarelin—Shock—Hydrocortisone—asthma	0.000205	0.000305	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ADRB2—asthma	0.000205	0.000646	CbGpPWpGaD
Nafarelin—Myalgia—Triamcinolone—asthma	0.000205	0.000305	CcSEcCtD
Nafarelin—Arthralgia—Methylprednisolone—asthma	0.000205	0.000304	CcSEcCtD
Nafarelin—Myalgia—Methylprednisolone—asthma	0.000205	0.000304	CcSEcCtD
Nafarelin—Hyperhidrosis—Hydrocortisone—asthma	0.000202	0.0003	CcSEcCtD
Nafarelin—Anorexia—Hydrocortisone—asthma	0.000199	0.000296	CcSEcCtD
Nafarelin—Oedema—Triamcinolone—asthma	0.000197	0.000292	CcSEcCtD
Nafarelin—Vertigo—Dexamethasone—asthma	0.000196	0.000292	CcSEcCtD
Nafarelin—Vertigo—Betamethasone—asthma	0.000196	0.000292	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ITPR1—asthma	0.000194	0.000611	CbGpPWpGaD
Nafarelin—Shock—Triamcinolone—asthma	0.000193	0.000288	CcSEcCtD
Nafarelin—Insomnia—Prednisolone—asthma	0.000193	0.000288	CcSEcCtD
Nafarelin—Alopecia—Prednisone—asthma	0.000193	0.000287	CcSEcCtD
Nafarelin—Shock—Methylprednisolone—asthma	0.000193	0.000287	CcSEcCtD
Nafarelin—Paraesthesia—Prednisolone—asthma	0.000192	0.000285	CcSEcCtD
Nafarelin—Mental disorder—Prednisone—asthma	0.000192	0.000285	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—RHOA—asthma	0.000191	0.000602	CbGpPWpGaD
Nafarelin—Malnutrition—Prednisone—asthma	0.00019	0.000283	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Hydrocortisone—asthma	0.00019	0.000283	CcSEcCtD
Nafarelin—Hyperhidrosis—Triamcinolone—asthma	0.00019	0.000283	CcSEcCtD
Nafarelin—Hyperhidrosis—Methylprednisolone—asthma	0.00019	0.000282	CcSEcCtD
Nafarelin—Convulsion—Betamethasone—asthma	0.000189	0.000282	CcSEcCtD
Nafarelin—Convulsion—Dexamethasone—asthma	0.000189	0.000282	CcSEcCtD
Nafarelin—Insomnia—Hydrocortisone—asthma	0.000189	0.000281	CcSEcCtD
Nafarelin—Paraesthesia—Hydrocortisone—asthma	0.000188	0.000279	CcSEcCtD
Nafarelin—Myalgia—Dexamethasone—asthma	0.000186	0.000277	CcSEcCtD
Nafarelin—Myalgia—Betamethasone—asthma	0.000186	0.000277	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CD86—asthma	0.000185	0.000582	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CXCL8—asthma	0.000185	0.000582	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EDN1—asthma	0.000183	0.000577	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL5—asthma	0.000182	0.000573	CbGpPWpGaD
Nafarelin—Decreased appetite—Hydrocortisone—asthma	0.000182	0.00027	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PLA2G4A—asthma	0.000181	0.000571	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CSF2—asthma	0.000179	0.000564	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Triamcinolone—asthma	0.000179	0.000266	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methylprednisolone—asthma	0.000179	0.000266	CcSEcCtD
Nafarelin—Oedema—Dexamethasone—asthma	0.000178	0.000265	CcSEcCtD
Nafarelin—Oedema—Betamethasone—asthma	0.000178	0.000265	CcSEcCtD
Nafarelin—Insomnia—Triamcinolone—asthma	0.000178	0.000264	CcSEcCtD
Nafarelin—Insomnia—Methylprednisolone—asthma	0.000177	0.000264	CcSEcCtD
Nafarelin—Paraesthesia—Triamcinolone—asthma	0.000177	0.000263	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—IL2—asthma	0.000177	0.000556	CbGpPWpGaD
Nafarelin—Paraesthesia—Methylprednisolone—asthma	0.000176	0.000262	CcSEcCtD
Nafarelin—Shock—Dexamethasone—asthma	0.000176	0.000261	CcSEcCtD
Nafarelin—Shock—Betamethasone—asthma	0.000176	0.000261	CcSEcCtD
Nafarelin—Dyspnoea—Triamcinolone—asthma	0.000175	0.000261	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—SMAD3—asthma	0.000174	0.000549	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Dexamethasone—asthma	0.000172	0.000256	CcSEcCtD
Nafarelin—Hyperhidrosis—Betamethasone—asthma	0.000172	0.000256	CcSEcCtD
Nafarelin—Vertigo—Prednisone—asthma	0.000171	0.000254	CcSEcCtD
Nafarelin—Anorexia—Betamethasone—asthma	0.00017	0.000253	CcSEcCtD
Nafarelin—Anorexia—Dexamethasone—asthma	0.00017	0.000253	CcSEcCtD
Nafarelin—Urticaria—Prednisolone—asthma	0.00017	0.000253	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CXCL8—asthma	0.000168	0.000528	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PPP2CA—asthma	0.000167	0.000526	CbGpPWpGaD
Nafarelin—Urticaria—Hydrocortisone—asthma	0.000166	0.000247	CcSEcCtD
Nafarelin—Convulsion—Prednisone—asthma	0.000165	0.000245	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCR5—asthma	0.000164	0.000516	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Betamethasone—asthma	0.000163	0.000242	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Dexamethasone—asthma	0.000163	0.000242	CcSEcCtD
Nafarelin—Myalgia—Prednisone—asthma	0.000162	0.000241	CcSEcCtD
Nafarelin—Arthralgia—Prednisone—asthma	0.000162	0.000241	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—IL2RA—asthma	0.000162	0.000509	CbGpPWpGaD
Nafarelin—Insomnia—Dexamethasone—asthma	0.000161	0.00024	CcSEcCtD
Nafarelin—Insomnia—Betamethasone—asthma	0.000161	0.00024	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—IL2—asthma	0.00016	0.000505	CbGpPWpGaD
Nafarelin—Paraesthesia—Dexamethasone—asthma	0.00016	0.000238	CcSEcCtD
Nafarelin—Paraesthesia—Betamethasone—asthma	0.00016	0.000238	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—C3—asthma	0.00016	0.000504	CbGpPWpGaD
Nafarelin—Urticaria—Triamcinolone—asthma	0.000156	0.000232	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PDGFB—asthma	0.000156	0.000491	CbGpPWpGaD
Nafarelin—Urticaria—Methylprednisolone—asthma	0.000156	0.000232	CcSEcCtD
Nafarelin—Oedema—Prednisone—asthma	0.000155	0.000231	CcSEcCtD
Nafarelin—Decreased appetite—Dexamethasone—asthma	0.000155	0.000231	CcSEcCtD
Nafarelin—Decreased appetite—Betamethasone—asthma	0.000155	0.000231	CcSEcCtD
Nafarelin—Shock—Prednisone—asthma	0.000153	0.000227	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisone—asthma	0.00015	0.000223	CcSEcCtD
Nafarelin—Asthenia—Hydrocortisone—asthma	0.00015	0.000223	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—LEP—asthma	0.000149	0.00047	CbGpPWpGaD
Nafarelin—Anorexia—Prednisone—asthma	0.000148	0.00022	CcSEcCtD
Nafarelin—Pruritus—Hydrocortisone—asthma	0.000148	0.00022	CcSEcCtD
Nafarelin—Diarrhoea—Hydrocortisone—asthma	0.000143	0.000212	CcSEcCtD
Nafarelin—Urticaria—Betamethasone—asthma	0.000142	0.000211	CcSEcCtD
Nafarelin—Urticaria—Dexamethasone—asthma	0.000142	0.000211	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Prednisone—asthma	0.000142	0.00021	CcSEcCtD
Nafarelin—Dizziness—Prednisolone—asthma	0.000141	0.00021	CcSEcCtD
Nafarelin—Asthenia—Triamcinolone—asthma	0.000141	0.00021	CcSEcCtD
Nafarelin—Asthenia—Methylprednisolone—asthma	0.000141	0.000209	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—FN1—asthma	0.000141	0.000443	CbGpPWpGaD
Nafarelin—Insomnia—Prednisone—asthma	0.000141	0.000209	CcSEcCtD
Nafarelin—Paraesthesia—Prednisone—asthma	0.00014	0.000207	CcSEcCtD
Nafarelin—Pruritus—Triamcinolone—asthma	0.000139	0.000207	CcSEcCtD
Nafarelin—Pruritus—Methylprednisolone—asthma	0.000139	0.000206	CcSEcCtD
Nafarelin—Dizziness—Hydrocortisone—asthma	0.000138	0.000205	CcSEcCtD
Nafarelin—Decreased appetite—Prednisone—asthma	0.000135	0.000201	CcSEcCtD
Nafarelin—Rash—Prednisolone—asthma	0.000135	0.0002	CcSEcCtD
Nafarelin—Dermatitis—Prednisolone—asthma	0.000135	0.0002	CcSEcCtD
Nafarelin—Diarrhoea—Methylprednisolone—asthma	0.000134	0.0002	CcSEcCtD
Nafarelin—Headache—Prednisolone—asthma	0.000134	0.000199	CcSEcCtD
Nafarelin—Constipation—Prednisone—asthma	0.000133	0.000198	CcSEcCtD
Nafarelin—Vomiting—Hydrocortisone—asthma	0.000133	0.000197	CcSEcCtD
Nafarelin—Rash—Hydrocortisone—asthma	0.000132	0.000196	CcSEcCtD
Nafarelin—Dermatitis—Hydrocortisone—asthma	0.000132	0.000196	CcSEcCtD
Nafarelin—Headache—Hydrocortisone—asthma	0.000131	0.000195	CcSEcCtD
Nafarelin—Dizziness—Triamcinolone—asthma	0.00013	0.000193	CcSEcCtD
Nafarelin—Dizziness—Methylprednisolone—asthma	0.00013	0.000193	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—POMC—asthma	0.000128	0.000403	CbGpPWpGaD
Nafarelin—Asthenia—Dexamethasone—asthma	0.000128	0.00019	CcSEcCtD
Nafarelin—Asthenia—Betamethasone—asthma	0.000128	0.00019	CcSEcCtD
Nafarelin—Nausea—Prednisolone—asthma	0.000127	0.000189	CcSEcCtD
Nafarelin—Pruritus—Betamethasone—asthma	0.000126	0.000188	CcSEcCtD
Nafarelin—Pruritus—Dexamethasone—asthma	0.000126	0.000188	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCL2—asthma	0.000125	0.000395	CbGpPWpGaD
Nafarelin—Vomiting—Triamcinolone—asthma	0.000125	0.000186	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—IL6R—asthma	0.000125	0.000393	CbGpPWpGaD
Nafarelin—Vomiting—Methylprednisolone—asthma	0.000125	0.000185	CcSEcCtD
Nafarelin—Nausea—Hydrocortisone—asthma	0.000124	0.000184	CcSEcCtD
Nafarelin—Rash—Triamcinolone—asthma	0.000124	0.000184	CcSEcCtD
Nafarelin—Dermatitis—Triamcinolone—asthma	0.000124	0.000184	CcSEcCtD
Nafarelin—Rash—Methylprednisolone—asthma	0.000124	0.000184	CcSEcCtD
Nafarelin—Dermatitis—Methylprednisolone—asthma	0.000124	0.000184	CcSEcCtD
Nafarelin—Urticaria—Prednisone—asthma	0.000123	0.000184	CcSEcCtD
Nafarelin—Headache—Triamcinolone—asthma	0.000123	0.000183	CcSEcCtD
Nafarelin—Headache—Methylprednisolone—asthma	0.000123	0.000183	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—EGFR—asthma	0.000123	0.000386	CbGpPWpGaD
Nafarelin—Diarrhoea—Dexamethasone—asthma	0.000122	0.000182	CcSEcCtD
Nafarelin—Diarrhoea—Betamethasone—asthma	0.000122	0.000182	CcSEcCtD
Nafarelin—Dizziness—Betamethasone—asthma	0.000118	0.000175	CcSEcCtD
Nafarelin—Dizziness—Dexamethasone—asthma	0.000118	0.000175	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—SERPINE1—asthma	0.000117	0.000368	CbGpPWpGaD
Nafarelin—Nausea—Triamcinolone—asthma	0.000117	0.000174	CcSEcCtD
Nafarelin—Nausea—Methylprednisolone—asthma	0.000117	0.000173	CcSEcCtD
Nafarelin—Vomiting—Betamethasone—asthma	0.000113	0.000169	CcSEcCtD
Nafarelin—Vomiting—Dexamethasone—asthma	0.000113	0.000169	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—RHOA—asthma	0.000113	0.000355	CbGpPWpGaD
Nafarelin—Rash—Dexamethasone—asthma	0.000112	0.000167	CcSEcCtD
Nafarelin—Rash—Betamethasone—asthma	0.000112	0.000167	CcSEcCtD
Nafarelin—Dermatitis—Betamethasone—asthma	0.000112	0.000167	CcSEcCtD
Nafarelin—Dermatitis—Dexamethasone—asthma	0.000112	0.000167	CcSEcCtD
Nafarelin—Headache—Betamethasone—asthma	0.000112	0.000166	CcSEcCtD
Nafarelin—Headache—Dexamethasone—asthma	0.000112	0.000166	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—NOS3—asthma	0.000112	0.000352	CbGpPWpGaD
Nafarelin—Asthenia—Prednisone—asthma	0.000111	0.000166	CcSEcCtD
Nafarelin—Pruritus—Prednisone—asthma	0.00011	0.000163	CcSEcCtD
Nafarelin—Diarrhoea—Prednisone—asthma	0.000106	0.000158	CcSEcCtD
Nafarelin—Nausea—Betamethasone—asthma	0.000106	0.000158	CcSEcCtD
Nafarelin—Nausea—Dexamethasone—asthma	0.000106	0.000158	CcSEcCtD
Nafarelin—Dizziness—Prednisone—asthma	0.000103	0.000153	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CXCL8—asthma	9.91e-05	0.000312	CbGpPWpGaD
Nafarelin—Vomiting—Prednisone—asthma	9.88e-05	0.000147	CcSEcCtD
Nafarelin—Rash—Prednisone—asthma	9.8e-05	0.000146	CcSEcCtD
Nafarelin—Dermatitis—Prednisone—asthma	9.79e-05	0.000146	CcSEcCtD
Nafarelin—Headache—Prednisone—asthma	9.73e-05	0.000145	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—IL2—asthma	9.47e-05	0.000298	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6—asthma	9.42e-05	0.000297	CbGpPWpGaD
Nafarelin—Nausea—Prednisone—asthma	9.23e-05	0.000137	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—MMP9—asthma	8.96e-05	0.000282	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PTEN—asthma	8.91e-05	0.000281	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—VEGFA—asthma	8.05e-05	0.000253	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—STAT3—asthma	7.97e-05	0.000251	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TGFB1—asthma	7.39e-05	0.000233	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EGFR—asthma	7.24e-05	0.000228	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6—asthma	5.57e-05	0.000175	CbGpPWpGaD
